Compass Pathways Plc (CMPS) - Total Liabilities
Based on the latest financial reports, Compass Pathways Plc (CMPS) has total liabilities worth $263.20 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Compass Pathways Plc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Compass Pathways Plc - Total Liabilities Trend (2018–2025)
This chart illustrates how Compass Pathways Plc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CMPS total asset value.
Compass Pathways Plc Competitors by Total Liabilities
The table below lists competitors of Compass Pathways Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Luxin Packing Materials Science&Technology Co Ltd
SHE:002565
|
China | CN¥589.25 Million |
|
Amprius Technologies Inc.
NYSE:AMPX
|
USA | $23.55 Million |
|
Dehua TB New Decoration Material Co Ltd
SHE:002043
|
China | CN¥2.52 Billion |
|
Derichebourg
PA:DBG
|
France | €1.44 Billion |
|
CVR Partners LP
NYSE:UAN
|
USA | $710.25 Million |
|
PCBL LIMITED
NSE:PCBL
|
India | Rs-40.19 Billion |
|
Grandjoy Holdings Group Co Ltd
SHE:000031
|
China | CN¥126.11 Billion |
|
CT Real Estate Investment Trust
TO:CRT-UN
|
Canada | CA$3.33 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Compass Pathways Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CMPS net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -4.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Compass Pathways Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Compass Pathways Plc (2018–2025)
The table below shows the annual total liabilities of Compass Pathways Plc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $263.20 Million | +346.32% |
| 2024-12-31 | $58.97 Million | +17.37% |
| 2023-12-31 | $50.24 Million | +213.74% |
| 2022-12-31 | $16.01 Million | -2.86% |
| 2021-12-31 | $16.49 Million | +139.10% |
| 2020-12-31 | $6.89 Million | -71.12% |
| 2019-12-31 | $23.87 Million | -41.43% |
| 2018-12-31 | $40.75 Million | -- |
About Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly … Read more